WASHINGTON, D.C.Routine measurement of fractional flow reserve (FFR) during DES-stenting in patients with multi-vessel disease is superior to current angiography guided treatment, according to the FAME late-breaking clinical trial presented Tuesday at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

WASHINGTON, D.C.The two-year data comparing Medtronics Endeavor zotarolimus-eluting stent and Boston Scientifics Taxus paclitaxel-eluting stent in patients with coronary artery disease demonstrated similar efficacy outcomes;however, safety results seem to trending slightly in favor of Endeavor, according to a late breaking clinical trial presented Tuesday at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

WASHINGTON, D.C.Six months after the launch of a new treatment approach designed to significantly lower mortality rates among patients experiencing heart attacks, Detroit Medical Center (DMC) has successfully reduced the critically importantdoor-to-angioplasty balloon (D2B)treatment time for heart attack patients by half, according to a presentation Monday at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

WASHINGTON, D.C.In patients at high risk for radiocontrast nephropathy (RCN) undergoing invasive cardiology procedures, cooling may be safely achieved and is well-tolerated, but those results do not point to a significant reduction in RCN, according to a late-breaking clinical trial presented Tuesday at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

WASHINGTON, D.C.Medical Simulation Corporation (MSC) has teamed up with Boston Scientific to provide product- and procedure-based simulation experiences aboard Boston Scientifics Mobile Simulation Labs to attendees of the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

WASHINGTON, D.C.The merger of MEDRAD and Possis Medical has resulted in a new cardiovascular products division named MEDRAD Interventional/Possis. The company is exhibiting this week at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

WASHINGTONTriple-antiplatelet therapy for patients undergoing PCI with drug-eluting stents achieves greater platelet inhibition than conventional dual-antiplatelet therapy, based on the results of five research studies and a clinical registry first-report presentation highlighted on Monday at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

WASHINGTONThe door-to-balloon (D2B) initiative launched by the American College of Cardiology in 2006 has been successful for those who have taken steps to reduce the time it takes to get STEMI patients to the cath lab. A poll of the audience at the Nurse & Technologist Symposium at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium on Monday morning, however, revealed that 35 percent of them werent even aware of the program.